Immunohistochemical study of solitary fibrous tumor in the ear related
to pazopanib use
- Toshiaki Kawano
, - Takashi Hirano,
- Maki Fujinaga,
- Yoshinori Kadowaki,
- Takayuki Matsunaga,
- Kaori Tateyama,
- Yumi Kizu,
- Masashi Suzuki
Abstract
This is the first report using an anti-tumor drug called Pazopanib for a
case of solitary fibrous tumor that occurred in the ear canal. Pazopanib
will be useful for clinicians involved in this case in the future, we
have reported the detailed progress and immunological analysis.18 Nov 2020Submitted to Clinical Case Reports 21 Nov 2020Submission Checks Completed
21 Nov 2020Assigned to Editor
07 Dec 2020Reviewer(s) Assigned
26 Dec 2020Review(s) Completed, Editorial Evaluation Pending
26 Dec 2020Editorial Decision: Revise Minor
29 Jan 20211st Revision Received
01 Feb 2021Submission Checks Completed
01 Feb 2021Assigned to Editor
01 Feb 2021Review(s) Completed, Editorial Evaluation Pending
01 Mar 2021Editorial Decision: Accept
